BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 20546196)

  • 1. Association between beta-adrenoceptor gene polymorphisms and relative response to beta 2-agonists and anticholinergic drugs in Japanese asthmatic patients.
    Asano K; Yamada-Yamasawa W; Kudoh H; Matsuzaki T; Nakajima T; Hakuno H; Hiraoka R; Fukunaga K; Oguma T; Sayama K; Yamaguchi K; Nagabukuro A; Harada Y; Ishizaka A
    Respirology; 2010 Jul; 15(5):849-54. PubMed ID: 20546196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tachyphylaxis to beta2-agonists in Spanish asthmatic patients could be modulated by beta2-adrenoceptor gene polymorphisms.
    Tellería JJ; Blanco-Quirós A; Muntión S; Antonio Garrote J; Arranz E; Armentia A; Díez I; Castro J
    Respir Med; 2006 Jun; 100(6):1072-8. PubMed ID: 16263254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenetics of asthma.
    Hawkins GA; Peters SP
    Methods Mol Biol; 2008; 448():359-78. PubMed ID: 18370237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta 2 adrenergic receptor polymorphisms in cystic fibrosis.
    Hart MA; Konstan MW; Darrah RJ; Schluchter MD; Storfer-Isser A; Xue L; Londono D; Goddard KA; Drumm ML
    Pediatr Pulmonol; 2005 Jun; 39(6):544-50. PubMed ID: 15806595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta(2)-adrenergic receptor polymorphisms and response to salbutamol among Indian asthmatics*.
    Kukreti R; Bhatnagar P; B-Rao C; Gupta S; Madan B; Das C; Guleria R; Athavale AU; Brahmachari SK; Ghosh B
    Pharmacogenomics; 2005 Jun; 6(4):399-410. PubMed ID: 16004558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salmeterol response is not affected by beta2-adrenergic receptor genotype in subjects with persistent asthma.
    Bleecker ER; Yancey SW; Baitinger LA; Edwards LD; Klotsman M; Anderson WH; Dorinsky PM
    J Allergy Clin Immunol; 2006 Oct; 118(4):809-16. PubMed ID: 17030231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent developments in the genetics of asthma.
    He JQ; Joos L; Sandford AJ
    Pharmacogenomics; 2001 Nov; 2(4):329-39. PubMed ID: 11722283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacogenetic tests in asthma therapy.
    Yu IW; Bukaveckas BL
    Clin Lab Med; 2008 Dec; 28(4):645-65. PubMed ID: 19059068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arginase 1 and arginase 2 variations associate with asthma, asthma severity and beta2 agonist and steroid response.
    Vonk JM; Postma DS; Maarsingh H; Bruinenberg M; Koppelman GH; Meurs H
    Pharmacogenet Genomics; 2010 Mar; 20(3):179-86. PubMed ID: 20124949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Asthma in the elderly].
    Radenne F; Verkindre C; Tonnel AB
    Rev Mal Respir; 2003 Feb; 20(1 Pt 1):95-103. PubMed ID: 12709638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bronchodilator response in relation to beta2-adrenoceptor haplotype in patients with asthma.
    Taylor DR; Epton MJ; Kennedy MA; Smith AD; Iles S; Miller AL; Littlejohn MD; Cowan JO; Hewitt T; Swanney MP; Brassett KP; Herbison GP
    Am J Respir Crit Care Med; 2005 Sep; 172(6):700-3. PubMed ID: 15976384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Part IV: Genetic variations in beta2-adrenergic receptors: long-acting and short-acting beta2-agonists and therapeutic response.
    Peters S
    Curr Med Res Opin; 2007 Sep; 23 Suppl 3():S29-36. PubMed ID: 17925066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacogenetics of β2 adrenergic receptor gene polymorphisms, long-acting β-agonists and asthma.
    Chung LP; Waterer G; Thompson PJ
    Clin Exp Allergy; 2011 Mar; 41(3):312-26. PubMed ID: 21294785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Asthma in the elderly].
    Drira I; Abouda M; Maalej S; Bourguiba M; Fennira H; Ben Kheder A
    Tunis Med; 2006 May; 84(5):327-30. PubMed ID: 16915788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recognition of asthma in adolescents and young adults: which objective measure is best?
    Ulrik CS; Postma DS; Backer V
    J Asthma; 2005 Sep; 42(7):549-54. PubMed ID: 16169787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Polymorphism of beta 2-adrenergic receptors].
    Weglarz L; Grzanka A; Kierot J; Wilczok T
    Wiad Lek; 2003; 56(5-6):283-8. PubMed ID: 14526489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetics and the variability of treatment response in asthma.
    Israel E
    J Allergy Clin Immunol; 2005 Apr; 115(4 Suppl):S532-8. PubMed ID: 15806036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta2-adrenergic receptor genetic polymorphisms and short-term bronchodilator responses in patients with COPD.
    Hizawa N; Makita H; Nasuhara Y; Betsuyaku T; Itoh Y; Nagai K; Hasegawa M; Nishimura M
    Chest; 2007 Nov; 132(5):1485-92. PubMed ID: 17890463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Confirmed beta16 Arg/Arg polymorphism in a patient with uncontrolled asthma.
    Metzger NL; Kockler DR; Gravatt LA
    Ann Pharmacother; 2008 Jun; 42(6):874-81. PubMed ID: 18430791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticholinergic agents in asthma: chronic bronchodilator therapy, relief of acute severe asthma, reduction of chronic viral inflammation and prevention of airway remodeling.
    Kanazawa H
    Curr Opin Pulm Med; 2006 Jan; 12(1):60-7. PubMed ID: 16357581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.